Compare Incyte Corporation (INCY) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Incyte Corporation trades at $112.77 (market cap $22.85B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.61 (market cap $24.42B). The key difference: Incyte Corporation and Direxion Daily Semiconductor Bull 3X Shares are close in size by market cap, and Incyte Corporation is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Incyte Corporation for 33 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| INCY | SOXL | |
|---|---|---|
Market Cap | $22.85B | $24.42B |
Volume | 1,927,029 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $129.93 | $300.77 |
52-Week Low | $83.80 | $30.81 |
Typical Hold Time | 33 Days | 15 Days |
Enterprise Value | $18.35B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Incyte (INCY) trades at $113.61, up 0.15% on the day, with a mixed technical signal leaning bearish. The company reported strong 2025 results with revenue of $5.14B and net income of $1.29B, and recent earnings beats in Q1 and Q2 2026. Key developments include FDA approval for Atebrioz and a strategic focus on post-JAKAFI growth targeting $4B in non-JAKAFI sales by 2029.
The outlook is cautiously optimistic, supported by robust profitability and pipeline progress, but tempered by near-term earnings pressure and technical weakness. Risks include JAKAFI's patent expiration after 2029 and competitive threats. Analysts maintain a Buy consensus with a $132.43 price target, implying significant upside from current levels.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.3, down 12.34% in the last 24 hours amid semiconductor sector volatility. Technical indicators show a bearish overall signal with mixed moving averages and neutral oscillators. The fund's leveraged structure amplifies both gains and losses in the semiconductor sector, which faces conflicting signals from strong AI demand versus concerns about valuation and regulatory risks.
The outlook for SOXL remains highly volatile, with opportunities tied to sustained AI-driven semiconductor demand but significant risks from the fund's 3x leverage structure and sector-specific headwinds. Investors face amplified exposure to semiconductor stock fluctuations, requiring careful risk management given the current bearish technical setup and mixed market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
